Researchers studying ageing in tiny ‘live’ models of the human brain have found a key to potential treatments for Alzheimer’s and other neurodegenerative diseases.
Improving a “trial-and-error approach’’ to epilepsy treatment is the aim of research that encompasses stem cells, artificial intelligence, brain organoids and drug screening.
A pilot facility at AIBN could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.
AIBN researchers have developed a diagnostic device, called an Immuno-storm chip, that could identify which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.
A startup company developing technology based on University of Queensland (UQ) research has announced it will partner with the US Government to test its needle-free vaccine delivery technology.